Stay updated on Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    15 days ago
    Change Detected
    Summary
    Padua, Italy was removed and Padova, Italy was added in the study locations.
    Difference
    0.2%
    Check dated 2026-04-06T03:22:11.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Added a Publication entry for the study: 'First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial' with PubMed attribution, including the author list and Naples, Italy affiliation.
    Difference
    0.2%
    Check dated 2026-03-22T22:01:55.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page revision entry was updated from v3.4.2 to v3.4.3. The change adds Revision: v3.4.3 and removes Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-08T12:39:30.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page update adds a Gastric cancer tag and a new link to the Genetic and Rare Diseases Information Center in the Resources section, and it updates the revision from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T15:48:50.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:14:40.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Introduced a glossary toggle and added QC-related metadata (Last Update Submitted that Met QC Criteria and Last Update Posted) with revision updated to v3.4.0. Removed the previous QC label (Last Update Submitted that met QC Criteria), the estimated Last Update Posted label, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-22T20:39:10.000Z thumbnail image

Stay in the know with updates to Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.